• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.

作者信息

Felker G Michael, Pang Peter S, Adams Kirkwood F, Cleland John G F, Cotter Gad, Dickstein Kenneth, Filippatos Gerasimos S, Fonarow Gregg C, Greenberg Barry H, Hernandez Adrian F, Khan Sadiya, Komajda Michel, Konstam Marvin A, Liu Peter P, Maggioni Aldo P, Massie Barry M, McMurray John J, Mehra Mandeep, Metra Marco, O'Connell John, O'Connor Christopher M, Pina Ileana L, Ponikowski Piotr, Sabbah Hani N, Teerlink John R, Udelson James E, Yancy Clyde W, Zannad Faiez, Gheorghiade Mihai

机构信息

Duke Clinical Research Institute Durham, NC, USA.

出版信息

Circ Heart Fail. 2010 Mar;3(2):314-25. doi: 10.1161/CIRCHEARTFAILURE.109.893222.

DOI:10.1161/CIRCHEARTFAILURE.109.893222
PMID:20233993
Abstract
摘要

相似文献

1
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.急性心力衰竭综合征药物治疗的临床试验：经验教训与未来方向。
Circ Heart Fail. 2010 Mar;3(2):314-25. doi: 10.1161/CIRCHEARTFAILURE.109.893222.
2
A global rank end point for clinical trials in acute heart failure.急性心力衰竭临床试验的全球排名终点。
Circ Heart Fail. 2010 Sep;3(5):643-6. doi: 10.1161/CIRCHEARTFAILURE.109.926030.
3
Surrogate and mediating endpoints: current status and future directions.替代终点和中介终点：现状与未来方向。
J Natl Cancer Inst. 2009 Feb 18;101(4):216-7. doi: 10.1093/jnci/djn515. Epub 2009 Feb 10.
4
[Learning from mistakes. Considerations on unsuccessful clinical trials of pharmacological therapies in acute heart failure].从错误中学习。关于急性心力衰竭药物治疗临床试验失败的思考
G Ital Cardiol (Rome). 2014 Jan;15(1):13-8. doi: 10.1714/1394.15513.
5
Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.“紧急呼吸困难研究”的设计与原理：一项国际多中心前瞻性研究。
Am J Ther. 2008 Jul-Aug;15(4):299-303. doi: 10.1097/MJT.0b013e31816b436e.
6
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).奈西立肽与多巴酚丁胺治疗心力衰竭的初步随机研究（PRESERVD-HF）的原理与设计
Am Heart J. 2003 Feb;145(2 Suppl):S55-7. doi: 10.1067/mhj.2003.155.
7
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.急性心力衰竭综合征的III期临床试验终点：与急性心力衰竭综合征国际工作组的虚拟圆桌会议
Am Heart J. 2009 Jun;157(6):957-70. doi: 10.1016/j.ahj.2009.04.010.
8
The rationale for an acute heart failure syndromes clinical trials network.急性心力衰竭综合征临床试验网络的基本原理。
J Card Fail. 2009 Aug;15(6):467-74. doi: 10.1016/j.cardfail.2008.12.013. Epub 2009 Feb 10.
9
Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.传染病临床试验中的微生物替代终点：以急性中耳炎试验为例。
Pharmacotherapy. 2005 Dec;25(12 Pt 2):109S-123S. doi: 10.1592/phco.2005.25.12part2.109S.
10
End-point selection for acute heart failure trials.终点选择在急性心力衰竭试验中。
Heart Fail Clin. 2011 Oct;7(4):481-95. doi: 10.1016/j.hfc.2011.06.007.

引用本文的文献

1
Trends in use of composite endpoints in clinical trials: A comparison between acute heart failure trials and COVID-19 trials.临床试验中复合终点的使用趋势：急性心力衰竭试验与COVID-19试验的比较。
J Clin Transl Sci. 2024 Mar 8;8(1):e55. doi: 10.1017/cts.2024.492. eCollection 2024.
2
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.高血压伴射血分数保留的急性和慢性心力衰竭的药物治疗：最新综述。
Am J Cardiovasc Drugs. 2024 May;24(3):343-369. doi: 10.1007/s40256-024-00641-9. Epub 2024 Apr 4.
3
Microengineered platforms for characterizing the contractile function of in vitro cardiac models.
用于表征体外心脏模型收缩功能的微工程平台。
Microsyst Nanoeng. 2022 Feb 28;8:26. doi: 10.1038/s41378-021-00344-0. eCollection 2022.
4
Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review.急诊科急性心力衰竭患者的风险分层评分：系统评价。
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):375-398. doi: 10.1177/2048872620930889.
5
Prevalence of Acute Coronary Syndrome and Various Risk Factors in Acute Stroke Patients.急性卒中患者中急性冠状动脉综合征及各种危险因素的患病率
Cureus. 2020 Aug 4;12(8):e9552. doi: 10.7759/cureus.9552.
6
Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations.急性失代偿性心力衰竭住院后患者的治疗：减少早期再住院的见解
Card Fail Rev. 2019 May 24;5(2):78-82. doi: 10.15420/cfr.2018.46.2. eCollection 2019 May.
7
High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial.高与低氧疗法治疗急性心力衰竭患者：HiLo-HF 试验研究。
ESC Heart Fail. 2019 Aug;6(4):667-677. doi: 10.1002/ehf2.12448. Epub 2019 May 17.
8
Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study.入院时血浆 2-氧戊二酸水平与急性心力衰竭患者短期预后的关系：一项前瞻性队列研究。
Mol Med. 2019 Mar 28;25(1):8. doi: 10.1186/s10020-019-0078-1.
9
Randomized double-blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis.随机双盲临床试验中乌利特肽和其他血管活性物质在急性失代偿性心力衰竭中的应用：系统评价和荟萃分析。
ESC Heart Fail. 2018 Dec;5(6):1023-1034. doi: 10.1002/ehf2.12349. Epub 2018 Sep 24.
10
A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.松弛素激素的单链衍生物是G蛋白偶联受体RXFP1的功能选择性激动剂。
Chem Sci. 2016 Jun 1;7(6):3805-3819. doi: 10.1039/c5sc04754d. Epub 2016 Feb 26.